dulaglutide and semaglutide versus once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial Study Displays the Benefits of

Document storage conditions for consistent laboratory quality control

1 2 "Recent advances in the pathophysiology and treatment of gastroparesis"

Epidermal growth factor receptor transactivation is necessary for glucagon-like peptide-1 to protect PC12 cells from apoptosis

In a clinical trial where neither the participants nor the researchers knew who received the actual drug or a fake pill (placebo), 314492 adults who were overweight or obese (with an average body mass index of 36.2) were randomly assigned to take either lorcaserin (10 mg) or placebo twice a day for 52 weeks

10 (7), e1003731

Fermentable fibers can raise the bodys own GLP-1 through short-chain fatty acid signaling and improve satiety and glucose control, but their standalone weight-loss effect is small, on the order of 0.3 to 0.8 kg versus control, compared with 10 to 20 kg or more for the drugs